Facilities & Capacity
thumbnail
Facilities & CapacityLilly injects another $5.3bn in Indiana plant to up tirzepatide productionLilly injects another $5.3bn in Indiana plant to up tirzepatide production
Eli Lilly has committed an additional $5.3 billion to bolster capacity to manufacture active pharmaceutical ingredients (API) for its tirzepatide products, Zepbound and Mounjaro.